| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/23/2008 | US20080261871 Y2/Y4 Selective Receptor Agonists for Therapeutic Interventions |
| 10/23/2008 | US20080261869 For treating bacterial and viral infections; kits |
| 10/23/2008 | US20080261867 Soluble inhibitors of vascular endothelial growth factor and use thereof |
| 10/23/2008 | US20080261863 Pegylation of Vasoactive Intestinal Peptide (Vip) / Pituitary Adenylate Cyclase Activating Peptide (Pacap) Receptor 2 (Vpac2) Agonists and Methods of Use |
| 10/23/2008 | US20080261862 Integrin mediates proliferative signal provided by CD23 to pre-B cells; immobilized rodent cells; drug screening; anticancer agents; antiinflammatory agents |
| 10/23/2008 | US20080261833 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 10/23/2008 | US20080261316 Compositions and Methods For Enhancing the Identification of Prior Protein Prpsc |
| 10/23/2008 | US20080261311 Translation systems with orthogonal aminoacyl tRNA synthetase; membrane proteins |
| 10/23/2008 | US20080261302 Nucleotide sequences coding seladin-1polypeptide for use in treatment and prevention of alzheimer's disease |
| 10/23/2008 | US20080261273 PROCESS FOR PRODUCING HMG-CoA REDUCTASE INHIBITORS |
| 10/23/2008 | US20080261272 reporter system reflecting the transport process that transports GPI-anchored proteins to the cell wall was constructed and compounds inhibiting this process were discovered; antifungal agents; inhibiting expression of cell wall glycoproteins and preventing pathogens from showing pathogenicity; DNA |
| 10/23/2008 | US20080261271 Expression of hiv polypeptides and production of virus-like particles |
| 10/23/2008 | US20080261270 Expression vector comprising nucleotide sequences estrogen receptor protein for use in inhibition of heregulin binding and treatment of breast and prostate cancers |
| 10/23/2008 | US20080261256 Methods of assaying receptor activity and constructs useful in such methods |
| 10/23/2008 | US20080261252 Soluble Interleukin-1 Receptor Accessory Molecule |
| 10/23/2008 | US20080261234 Peptides and their use in assays for cardiovascular disease |
| 10/23/2008 | US20080261231 Nucleotide sequences coding angiotensinogen (AGT) gene for use as evaluative tool in diagnosing pancreatic disorders; disease screening through genomic variance |
| 10/23/2008 | US20080261228 Using prostate cancer antigen (PCA) expression as evaluative tool in diagnosis/prognosis of cancer |
| 10/23/2008 | US20080261224 PGC-1Beta, A Novel PGC-1 Homologue and Uses Therefor |
| 10/23/2008 | US20080261197 O retroviral protein for use as tool in detection, treatment and prevention of human immunodeficiency virus infection |
| 10/23/2008 | US20080260858 Universal Procoagulant |
| 10/23/2008 | US20080260847 polyglycolic acid or polylactic acid or glycolic acid-lactic acid copolymer as biocompatible polymer having dispersed therein an active agent such as exendin-4; antidiabetic agent |
| 10/23/2008 | US20080260830 suitable for regeneration, growth stimulation and differentiation of various cells, tissues and organs; growth/differentiation factors (GDFs); regeneration of connective tissue including tendon and/or ligament, periodontal or dental tissue including dental implants, neural tissue and sensory tissues |
| 10/23/2008 | US20080260794 Collagen products and methods for producing collagen products |
| 10/23/2008 | US20080260789 Expressed in venom glands of spiders; polynucleotides; transgenic plant or insect |
| 10/23/2008 | US20080260780 Materials and methods relating to improved vaccination strategies |
| 10/23/2008 | US20080260768 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 10/23/2008 | US20080260764 Variation in viral replication peptide as evaluative tool in predicting virulence in emerging influenza strains |
| 10/23/2008 | US20080260763 High Throughput Proteomics |
| 10/23/2008 | US20080260762 HLA binding motifs and peptides and their uses |
| 10/23/2008 | US20080260761 Compositions, Splice Variants and Methods Relating to Cancer Specific Genes and Proteins |
| 10/23/2008 | US20080260759 Novel Mite Allergen |
| 10/23/2008 | US20080260756 Peptide Inhibitors of iASPP |
| 10/23/2008 | US20080260755 Therapeutic fusion protein in which coagulation factor sequences are fused to half-life enhancing polypeptide for use in treatment of hemophilia |
| 10/23/2008 | US20080260752 Prevention and reduction of blood loss |
| 10/23/2008 | US20080260750 Polynucleotides Encoding Acetylcholine-Gated Chloride Channel Subunits of Caenorhabditis Elegans |
| 10/23/2008 | US20080260748 Desmocollin 2 (DSC2) specific immunoglobulin for use in prevention and treatment of cell proliferative disorders |
| 10/23/2008 | US20080260747 Adhesion interaction protein (CD-84) specific immunoglobulin for use in the treatment of cell proliferative disorders of the blood |
| 10/23/2008 | US20080260746 Erythropoietin polypeptide for use in treatment and prevention of viral, skin, nervous system, autoimmune, cardiovascular, kidney, cell proliferative and cardiovascular disorders |
| 10/23/2008 | US20080260745 Targeted identification of immunogenic peptides |
| 10/23/2008 | US20080260742 Preventives/Remedies for Cancer |
| 10/23/2008 | US20080260741 Preventive and/or Therapeutic Agent for Cancer |
| 10/23/2008 | US20080260721 Nucleotide sequences coding regulatory-associated protein of mTOR (Raptor) protein for use in identifying modulators for prevention and treatment of cancer and diabetes |
| 10/23/2008 | US20080260719 EDG: Modulators of lymphocyte activation and migration |
| 10/23/2008 | US20080260717 Methods for Reducing Seizure-Induced Neuronal Damage |
| 10/23/2008 | US20080260693 Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (lcmv) |
| 10/23/2008 | US20080260689 Mixture comprising Interleukin receptor amino acid sequences for use in developing vaccine for prevention and treatment of autoimmune diseases; genetic vaccines |
| 10/23/2008 | US20080260638 Receptor(sstr2)-selective somatostatin antagonists |
| 10/23/2008 | CA2688693A1 Interferons of rhesus and cynomolgus origin and uses thereof |
| 10/23/2008 | CA2684534A1 Constructs for enhancement of gene expression in muscle |
| 10/23/2008 | CA2684494A1 Fusion protein vaccine |
| 10/23/2008 | CA2684370A1 Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases |
| 10/23/2008 | CA2683912A1 Use of selected lactic acid bacteria for reducing atherosclerosis |
| 10/23/2008 | CA2683778A1 Prevention of staphylococcus biofilm formation |
| 10/23/2008 | CA2683463A1 Anti-tumor drug, medicament, composition, and use thereof |
| 10/23/2008 | CA2683454A1 Tem8 peptides and vaccines comprising the same |
| 10/23/2008 | CA2683443A1 Modified factor vii polypeptides and uses thereof |
| 10/23/2008 | CA2682350A1 Diagnosis and treatment of diseases caused by misfolded proteins |
| 10/23/2008 | CA2671540A1 Linear expression cassette vaccines |
| 10/23/2008 | CA2648864A1 Gene defects and mutant alk kinase in human solid tumors |
| 10/22/2008 | EP1983342A1 Antogonists of bitter taste receptors and uses thereof |
| 10/22/2008 | EP1983059A2 Process for producing dipeptides |
| 10/22/2008 | EP1983058A1 Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes |
| 10/22/2008 | EP1983055A1 Albumin fusion proteins |
| 10/22/2008 | EP1983053A2 Cell distribution control for cells within bioartifical organs |
| 10/22/2008 | EP1983001A2 Antibodies to mammalian Langerhans cell antigen and their uses |
| 10/22/2008 | EP1982998A1 Nucleic acid binding proteins |
| 10/22/2008 | EP1982997A1 Degradable clostridial toxins |
| 10/22/2008 | EP1982996A1 Degradable clostridial toxins |
| 10/22/2008 | EP1982995A1 Improved recombinant staphylokinases |
| 10/22/2008 | EP1982994A2 Carbohydrate-mimetic peptides and use thereof in pharmaceutical formulations |
| 10/22/2008 | EP1982993A2 Detection of primary infections with pathogens |
| 10/22/2008 | EP1982992A1 Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector |
| 10/22/2008 | EP1982990A1 Cytokine receptor common gamma chain like |
| 10/22/2008 | EP1982735A1 Electroprocessed collagen |
| 10/22/2008 | EP1982732A2 Factor VII or VIIA-like molecules |
| 10/22/2008 | EP1982008A1 Protein c pathway associated polymorphisms as response predictors to activated protein c or protein c like compound administration |
| 10/22/2008 | EP1981964A2 Mycobacterial seca2 mutants |
| 10/22/2008 | EP1981908A2 Novel fsh glycosylation variant d3n |
| 10/22/2008 | EP1981907A2 Method for producing epitomers and their uses on carrier microorganisms |
| 10/22/2008 | EP1981906A1 Human semen enhancer of viral infection peptides (sevi) and their use |
| 10/22/2008 | EP1981905A2 Chlamydia vaccine |
| 10/22/2008 | EP1981904A2 Peptide domain required for interaction between the envelope of a virus pertaining to the herv-w interference group and an hasct receptor |
| 10/22/2008 | EP1981902A2 Nogo receptor antagonists |
| 10/22/2008 | EP1981533A1 Vaccine and antigen mimotopes against cancerous diseases associated with the carcinoembryonic antigen cea |
| 10/22/2008 | EP1981526A2 Adiponectin for treatment of various disorders |
| 10/22/2008 | EP1981525A1 Extended release of neuregulin for improved cardiac function |
| 10/22/2008 | EP1981522A2 Compositions and methods for enhancing neuronal plasticity and regeneration |
| 10/22/2008 | EP1756575B1 Detection of methamphetamine group drugs |
| 10/22/2008 | EP1756156B1 Selective vpac2 receptor peptide agonists |
| 10/22/2008 | EP1560590B1 Synthetic complementary peptides and ophthalmologic uses thereof |
| 10/22/2008 | EP1532177B1 Immunomodulatory constructs and their uses |
| 10/22/2008 | EP1492881B1 Use of biological photoreceptors as directly light-activated ion channels |
| 10/22/2008 | EP1375518B1 Anti-osteopontin antibody and use thereof |
| 10/22/2008 | EP1374672B1 Drosophila strain carrying bradeion gene(s) transferred thereinto |
| 10/22/2008 | EP1368371B1 Transfection complexes |
| 10/22/2008 | EP1311679B1 Method for inhibiting il-22 induced pap1 |
| 10/22/2008 | EP1307565B1 Vaccins against marek's disease virus (mdv) and varicella zoster virus (vzv) |
| 10/22/2008 | EP1238275B1 Characterization of hybridized polymer molecules based on monomer-interface interactions |
| 10/22/2008 | EP1235861B1 Transgenic mouse expressing steroid-activated nuclear receptor |